Free Trial
→ IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead? (From American Alternative) (Ad)tc pixel

Mani Foroohar Analyst Performance

Analyst at Leerink Partners

Mani Foroohar is a stock analyst at Leerink Partners across a range of sectors, covering 14 publicly traded companies. Over the past year, Mani Foroohar has issued 5 stock ratings, including buy, hold, and sell recommendations. While full access to Mani Foroohar's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mani Foroohar's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Analyst Rating
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
18 Last 5 Years
Buy Recommendations
16.67% 3 Buy Ratings
Companies Covered
14 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy16.7%3 ratings
Hold55.6%10 ratings
Sell27.8%5 ratings

Out of 18 total stock ratings issued by Mani Foroohar at Leerink Partners, the majority (55.6%) have been Hold recommendations, followed by 27.8% Sell and 16.7% Buy.

Best & Worst Calls

Exchange Coverage

ExchangePercentageCount
NASDAQ
85.7% of companies on NASDAQ
12 companies
NYSE
14.3% of companies on NYSE
2 companies

Mani Foroohar, an analyst at Leerink Partners, currently covers 14 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
8 companies		57.1%
Retail/Wholesale
3 companies		21.4%
Computer and Technology
2 companies		14.3%
Business Services
1 company		7.1%

Mani Foroohar of Leerink Partners specializes in stock coverage within the Medical sector, with additional focus on Retail/Wholesale and Computer and Technology companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
4 companies		28.6%
MED - DRUGS
3 companies		21.4%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC
1 company		7.1%
FINANCIAL TRANSACTION SERVICES
1 company		7.1%
COMPUTER PROGRAMMING, DATA PROCESSING, & OTHER COMPUTER RELATED
1 company		7.1%
SEMI - GENERAL
1 company		7.1%
RETAIL - RESTRNTS
1 company		7.1%
INTERNET COMMERCE
1 company		7.1%
APPAREL & ACCESSORY STORES
1 company		7.1%

Mani Foroohar's Ratings History at Leerink Partners

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
Export to Excel
CompanyReport DateActionReport Date Price12-Month
Price Target		Rating12-Month
Price & ROI		Details
Moderna, Inc. stock logo
MRNA
Moderna
8/22/2025Lower Price Target$27.61$15.00Underperform
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
5/28/2025Reiterated Rating$2.33$8.00Market Perform
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
3/24/2025Lower Price Target$3.44$18.00Outperform
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
2/28/2025Lower Price Target$7.51$6.00Market Perform
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
1/13/2025Lower Price Target$4.80$27.00Outperform
Today's Ratings
Top-Rated Stocks
More Ratings Tools